Literature DB >> 26354880

Acute generalized exanthematous pustulosis (AGEP): A review and update.

Jesse Szatkowski1, Robert A Schwartz2.   

Abstract

Acute generalized exanthematous pustulosis is a severe cutaneous adverse reaction characterized by the rapid development of nonfollicular, sterile pustules on an erythematous base. It is attributed to drugs in the majority of cases. Antibiotics are the most common cause of acute generalized exanthematous pustulosis; however, a wide variety of drugs has been associated with this condition. Typically, within 48 hours of ingesting the causative medication, there is acute onset of fever and pustulosis with leukocytosis. In severe cases there can be mucous membrane and systemic organ involvement. Histologic findings include intracorneal, subcorneal, and/or intraepidermal pustules with papillary dermal edema containing neutrophils and eosinophils. Treatment focuses on removal of the causative drug, supportive care, infection prevention, and the often beneficial use of a potent topical steroid.
Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T cells; acute generalized exanthematous pustulosis; drug allergy; pustular drug eruption; pustules; severe cutaneous adverse reactions

Mesh:

Substances:

Year:  2015        PMID: 26354880     DOI: 10.1016/j.jaad.2015.07.017

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  47 in total

1.  Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance.

Authors:  Lisa Harinstein; Dipti Kalra; Cindy M Kortepeter; Monica A Muñoz; Eileen Wu; Gerald J Dal Pan
Journal:  Drug Saf       Date:  2019-05       Impact factor: 5.606

2.  Acute generalised exanthematous pustulosis due to amoxicillin-clavulanate.

Authors:  Nuno Gaibino; Miguel Bigotte Vieira; Paulo Filipe; Anabela Oliveira
Journal:  BMJ Case Rep       Date:  2016-03-22

3.  Hydrochlorothizide-induced acute generalised exanthematous pustulosis presenting with bilateral periorbital impetigo.

Authors:  Leo E Reap; Cassandra Rodd; Jose Larios; Michael Marshall
Journal:  BMJ Case Rep       Date:  2019-02-11

Review 4.  Recent advances in the understanding of severe cutaneous adverse reactions.

Authors:  N R Adler; A K Aung; E N Ergen; J Trubiano; M S Y Goh; E J Phillips
Journal:  Br J Dermatol       Date:  2017-09-29       Impact factor: 9.302

5.  Dupilumab-induced Acute Generalized Exanthematous Pustulosis in a 17-year-old Female Chinese Patient with Atopic Dermatitis.

Authors:  LiMing Wu; Kamran Ali; YunMi Qiu; MengHua Li; JiaYang Da
Journal:  Acta Derm Venereol       Date:  2022-06-29       Impact factor: 3.875

Review 6.  Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review).

Authors:  Emily L Coleman; Brianna Olamiju; Jonathan S Leventhal
Journal:  Oncol Rep       Date:  2020-12-24       Impact factor: 3.906

Review 7.  Cutaneous Adverse Effects of Neurologic Medications.

Authors:  Eman Bahrani; Chloe E Nunneley; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 6.497

Review 8.  Sulfonamide Drug Allergy.

Authors:  Joshua M Dorn; Mollie Alpern; Caitlin McNulty; Gerald W Volcheck
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-06       Impact factor: 4.919

Review 9.  Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.

Authors:  Kalliopi Gerogianni; Aspasia Tsezou; Konstantinos Dimas
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.476

10.  Acute generalized exanthematous pustulosis due to hydroxichloroquine.

Authors:  Giulia Odorici; Cecilia Schenetti; Lucrezia Pacetti; Natale Schettini; Alba Gaban; Lucia Mantovani
Journal:  Dermatol Ther       Date:  2022-04-23       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.